Bailard’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-5,000
| Closed | -$243K | – | 615 |
|
|
2019
Q3 | $243K | Sell |
5,000
-46,000
| -90% | -$2.24M | 0.01% | 440 |
|
|
2019
Q2 | $2.68M | Sell |
51,000
-12,900
| -20% | -$679K | 0.16% | 124 |
|
|
2019
Q1 | $3.38M | Buy |
63,900
+9,000
| +16% | +$476K | 0.21% | 102 |
|
|
2018
Q4 | $2.25M | Buy |
54,900
+22,000
| +67% | +$903K | 0.15% | 131 |
|
|
2018
Q3 | $1.25M | Sell |
32,900
-7,600
| -19% | -$289K | 0.07% | 195 |
|
|
2018
Q2 | $1.83M | Sell |
40,500
-1,000
| -2% | -$45.2K | 0.11% | 170 |
|
|
2018
Q1 | $2M | Sell |
41,500
-31,200
| -43% | -$1.51M | 0.13% | 163 |
|
|
2017
Q4 | $2.86M | Buy |
72,700
+27,000
| +59% | +$1.06M | 0.18% | 130 |
|
|
2017
Q3 | $1.42M | Hold |
45,700
| – | – | 0.11% | 147 |
|
|
2017
Q2 | $1.25M | Buy |
+45,700
| New | +$1.25M | 0.1% | 160 |
|